Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: Pathobiological mechanisms and clinical implications

Journal of Molecular Medicine

Volumn 90, Issue 10, 2012, Pages 1173-1184

  Menéndez, Sofía Tirados ^a   Villaronga, María Ángeles ^a   Rodrigo, Juan P ^a   Álvarez Teijeiro, Saúl ^a   García Carracedo, Darío ^a   Urdinguio, Rocío G ^a   Fraga, Mario F ^a,b   Pardo, Luis A ^c   Viloria, Cristina Gutiérrez ^a   Suárez, Carlos ^a   García Pedrero, Juana María ^a,d  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Cancer; Gene expression; Oncogene; Potassium channel; Prognosis; Real time PCR

Indexed keywords

POTASSIUM CHANNEL HERG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPIGENESIS, GENETIC; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; SEQUENCE ANALYSIS, DNA;

EID: 84867334589     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-012-0893-0     Document Type: Article

References (35)

1. Forastiere A, Koch W, Trotti A, Sidransky D (2001) Headandneck cancer. N Engl J Med 345:1890-1900
2. Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359:1143-1154
3. Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9-22
4. Niemeyer BA, Mery L, Zawar C, Suckow A, Monje F, Pardo LA, Stuhmer W, Flockerzi V, Hoth M (2001) Ion channels in health and disease. EMBO Rep 2:568-573
5. O'Grady SM, Lee SY (2005) Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. Int J Biochem Cell Biol 37:1578-1594
6. Kaczmarek LK (2006) Non-conducting functions of voltage-gated ion channels. Nat Rev Neurosci 7:761-771
7. Wang Z (2004) Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch 448:274-286
8. Kass RS (2005) The channelopathies: novel insights into molecular and genetic mechanisms of human disease. J Clin Invest 115:1986-1989
9. Wulff H, Castle NA, Pardo LA (2009) Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 8:982-1001
10. Pardo LA, Contreras-Jurado C, Zientkowska M, Alves F, Stühmer W (2005) Role of voltage-gated potassium channels in cancer. J Membr Biol 205:115-124
11. Nilius B, Wohlrab W (1992) Potassium channels and regulation of proliferation of human melanoma cells. J Physiol 445:537-548
12. Bianchi L, Wible B, Arcangeli A, Taglialatela M, Morra F, Castaldo P, Crociani O, Rosati B, Faravelli L, Olivotto M et al (1998) herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res 58:815-822
13. Smith GA, Tsui HW, Newell EW, Jiang X, Zhu XP, Tsui FW, Schlichter LC (2002) Functional upregulation of HERG K+channels in neoplastic hematopoietic cells. J Biol Chem 277:18528-18534
14. Pardo LA, del Camino D, Sánchez A, Alves F, Brüggemann A, Beckh S, Stühmer W (1999) Oncogenic potential of EAG K+ channels. EMBO J 18:5540-5547
15. Asher V, Sowter H, Shaw R, Bali A, Khan R (2010) Eag and HERG potassium channels as novel therapeutic targets in cancer. World J Surg Oncol 8:113
16. Pardo LA, Stühmer W (2008) Eag1: an emerging oncological target. Cancer Res 68:1611-1613
17. Hemmerlein B, Weseloh RM, Mello de Queiroz F, Knötgen H, Sánchez A, Rubio ME, Martin S, Schliephacke T, Jenke M, Heinz-Joachim-Radzun et al (2006) Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer 5:41
18. Mello de Queiroz F, Suarez-Kurtz G, Stühmer W, Pardo LA (2006) Ether à go-go potassium channel expression in soft tissue sarcoma patients. Mol Cancer 5:42
19. Agarwal JR, Griesinger F, Stühmer W, Pardo LA (2010) The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia. Mol Cancer 9:18
20. Pedrero JM, Carracedo DG, Pinto CM, Zapatero AH, Rodrigo JP, Nieto CS, Gonzalez MV (2005) Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma. Int J Cancer 114:242-248
21. Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM (2009) Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 217:516-523
22. Lansford CD, Grénman R, Bier H, Somers KD, Kim SY, Whiteside TL, Clayman GL, Welkoborsky HJ, Carey TE (1999) Head and neck cancers. In: Masters J, Palsson B (eds) Human cell culture. Kluwer, Dordrecht, pp 185-255
23. Hermsen MA, Joenje H, Arwert F, Welters MJ, Braakhuis BJ, Bagnay M, Westerveld A, Slater R (1996) Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Gene Chromosome Cancer 15:1-9
24. Calvanese V, Lara E, Suárez-Alvarez B, Abu Dawud R, Vázquez-Chantada M, Martínez-Chantar ML, Embade N, López-Nieva P, Horrillo A, Hmadcha A et al (2010) Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci U S A 107:13736-13741
25. Gómez-Varela D, Zwick-Wallasch E, Knötgen H, Sánchez A, Hettmann T, Ossipov D, Weseloh R, Contreras-Jurado C, Rothe M, Stühmer W et al (2007) Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res 67:7343-7349
26. Vindelov LL, Christensen IJ, Nissen NI (1983) Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 3:328-331
27. Li LC, Dahiya R (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics 18:1427-1431
28. Weber C, Mello de Queiroz F, Downie BR, Suckow A, Stühmer W, Pardo LA (2006) Silencing the activity and proliferative properties of the human EagI potassium channel by RNA interference. J Biol Chem 281:13030-13037
29. Downie BR, Sánchez A, Knötgen H, Contreras-Jurado C, Gymnopoulos M, Weber C, Stühmer W, Pardo LA (2008) Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J Biol Chem 283:36234-36240
30. Ousingsawat J, Spitzner M, Puntheeranurak S, Terracciano L, Tornillo L, Bubendorf L, Kunzelmann K, Schreiber R (2007) Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res 13:824-831
31. Restrepo-Angulo I, Sánchez-Torres C, Camacho J (2011) Human EAG1 potassium channels in the epithelial-to-mesenchymal transition in lung cancer cells. Anticancer Res 31:1265-1270
32. Namiki T, Yanagawa S, Izumo T, Ishikawa M, Tachibana M, Kawakami Y, Yokozeki H, Nishioka K, Kaneko Y (2005) Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. Cancer Genet Cytogenet 157:1-11
33. Bergamo NA, Rogatto SR, Poli-Frederico RC, Reis PP, Kowalski LP, Zielenska M, Squire JA (2000) Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas. Cancer Genet Cytogenet 119:48-55
34. Wagner JM, Hackanson B, Lübbert M, Jung M (2010) Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics 1:117-136
35. Lin H, Li Z, Chen C, Luo X, Xiao J, Dong D, Lu Y, Yang B, Wang Z (2011) Transcriptional and post-transcriptional mechanisms for oncogenic overexpression of ether à go-go K+ channel. PLoS One 6:e20362